The Indian Council of Medical Research (ICMR) is the apex body in India for the formulation, coordination and promotion of biomedical research. It was established in 1911 as the Indian Research Fund Association and was renamed ICMR in 1949. ICMR is funded by the Government of India and oversees intramural research through its 30 research institutes and centers as well as extramural research at universities and colleges. ICMR aims to support biomedical research in India and provide guidance on national health programs and ethical research practices.
An overview of ICH-GCP guidelines of clinical trials.
Good clinical practice (GCP): a standard for the design , conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate and that the rights, integrity, and confidentiality of trial subjects are protected.
ICH-GCP is an International Conference on Harmonization Good Clinical Practice.
The guideline was developed with consideration of the current good clinical practices of the European union, Japan, and the United States, as well as those of Australia, Canada, the Nordic countries and the world health organization
The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.
The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs.
These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction.
Table of contents
-Definition of CRF
-What is CRF
-Types & Methods of filling of CRF
-CRF Input team
-CRF Approval team
-Review team
-Facts about CRF
-Purpose of CRF
-CRF Development process & Guidelines
-Elements of CRF
-CRF Design
-CRF completion checklist
-CRF Design tools
-CRF use
-GCP connection
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSjyothibhat21
This presentation highlights the regulations on Ethical requirements for conducting clinical research in India. This is the guiding regulation for the Ethics Committees in India.
The viewers are requested to give their feedback on the utility of the presentation.
This presentation is a brief overview of ICH-GCP guidelines. Although ICH-GCP is a very vast topic, still this presentation will cover almost all the points. The reader will be able to discuss about the roles and responsibilities of various personnel in clinical trials.
An overview of ICH-GCP guidelines of clinical trials.
Good clinical practice (GCP): a standard for the design , conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate and that the rights, integrity, and confidentiality of trial subjects are protected.
ICH-GCP is an International Conference on Harmonization Good Clinical Practice.
The guideline was developed with consideration of the current good clinical practices of the European union, Japan, and the United States, as well as those of Australia, Canada, the Nordic countries and the world health organization
The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.
The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs.
These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction.
Table of contents
-Definition of CRF
-What is CRF
-Types & Methods of filling of CRF
-CRF Input team
-CRF Approval team
-Review team
-Facts about CRF
-Purpose of CRF
-CRF Development process & Guidelines
-Elements of CRF
-CRF Design
-CRF completion checklist
-CRF Design tools
-CRF use
-GCP connection
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSjyothibhat21
This presentation highlights the regulations on Ethical requirements for conducting clinical research in India. This is the guiding regulation for the Ethics Committees in India.
The viewers are requested to give their feedback on the utility of the presentation.
This presentation is a brief overview of ICH-GCP guidelines. Although ICH-GCP is a very vast topic, still this presentation will cover almost all the points. The reader will be able to discuss about the roles and responsibilities of various personnel in clinical trials.
WHO is a specialised non political health agency of the united nations and it is the directing and coordinating authority for health within the united nations system
WHO is working to ensure that everyone has access to quality health care.
In many countries, there is little money available to spend on health. This results in inadequate hospitals and clinics, a short supply of essential
medicines and equipment, and a critical shortage of health workers. Worse, in some parts of the world, large numbers of health workers are
dying from the very diseases which they are trying to prevent and treat.
WHO works with countries to help them plan, educate and manage the
health workforce, for example, by advising on policies to recruit and retain
people working in health.
The President notified the creation of the Department of Health Research under the Ministry of Health & Family Welfare through an amendment to the Government of India (Allocation of Business) Rules, 1961 on the 17th September , 2007 The Department of Health Research was formally launched on 5th October 2007 by the Minister for Science & Technology and Earth Sciences in a function presided over by the Minister for Health & Family Welfare, in the presence, inter-alia, of the Minister of State for Health & Family Welfare.
CCRAS (central council for reasearch in ayurvedic sciences)VK VIKRAM VARMA
Introduction
Sowa-Rigpa
CCRAS Website
CCRAS Vision & Mission
Organisation chart
Seniority List
Institutes
Research Activities
The Broad Areas of Research Comprise
Clinical Research
Fundamental Research
Pharmacology Research
Medicinal Plant Research, Drug Standardisation Research
Literature Research
AYUSH Research Portal
Outreach Activities
Publications
E-books
Reference
Ethical Dimensions in the Biomedical Innovations in India: An AnalysisAnup Kumar Das
Presentation titled "Ethical Dimensions in the Biomedical Innovations in India: An Analysis" was presented in the Second International Convention on Ethics in Research on Human Participants: Evolving Norms and Guidelines for the Indian Context, 2-4 September 2014, at JNU Convention Centre, New Delhi; Organized by Institutional Ethics Review Board, JNU, India.
Dr.Rahul Hajare is a post doctoral student of Renowned Scientist Respected Dr. R S. Paranjape Retired Director and Scientist ‘G’ National AIDS Research Institute India. He achieved his training at the National AIDS Research Institute, the reputed and primer HIV research institute in India. Dr. Hajare is board certified by Director-in-Charge, National AIDS Research Institute, the Secretory Board of Management KLE Society Belagavi, Registrar Vinayaka Mission’s Research Foundation, Aarti Drugs Limited and Shikshan Vikas Mandal. Dr Hajare won World Academic Championship-2017 in Pharmacy (Antiretroviral Therapy) and certified as Fellow, Directorate of Pharmacy, IASR (Lifetime Membership).
This guideline provides organised and systematic information on research procedures and requirements as well as research framework and principles that can comprehensively guide the researchers on the conduct of research in the Ministry of Health (MOH) facilities and institutions.
NIH Guidelines for Conducting Research in Ministry of Health Institutions & Facilities, 3rd Edition (2021). National Institutes of Health, Ministry of Health Malaysia.
ISBN: 978-967-5340-30-7
Indian Council of Medical Research (ICMR).pptxSamikshaHamane
Introduction
Objective
Organisation structure
Roles & responsibilities of ICMR
Intramural research & Extramural research
General principles
Ethical Review Procedures
Composition
Training & regulation
Open Access to Biomedical Research in India: Contributions Made by Indian Sci...Anup Kumar Das
Open Access to Biomedical Research in India: Contributions Made by Indian Scientists for Global Access;
Presented in KCL-JNU Workshop On Biomedical Innovation and the Public; Session: Open Access and Biomedical Innovation: Trends, Issues and the Way Forward. 13-14 March 2014, JNU Convention Centre, New Delhi
Organized by King's College London (KCL) and Jawaharlal Nehru University.
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...Swapnil Fernandes
- Nutraceutical market has shown steady increase in the last decade.
- The import, manufacture and marketing regulations for nutraceuticals in India have been streamlined with the updation of the FSSAI regulations 2016.
- RDA’s are a collection of values to express a person's nutrient need based on their life stage & gender.
- The RDA recommendations for the Indian population has been provided by the ICMR on the basis of scientific studies and subsequent data generated.
Similar to Indian council of medical research (ICMR) (20)
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Indian council of medical research (ICMR)
1. INDIAN COUNCIL OF MEDICAL RESEARCH
http://www.icmr.nic.in
Sagar Savale
Mr. Sagar Kishor Savale
[Department of Pharmaceutics]
avengersagar16@gmail.com
2015-2016
1 7/9/2016
3. Introduction
The ICMR, New Delhi, is one of the oldest medical
research body in the world and apex body in India.
The Indian Council of Medical Research (ICMR) is the
premier national agency for the
-planning
-formulation
-co-ordination
-implementation
-conduct or promotion of biomedical research in India.
Sagar Savale
3 7/9/2016
4. In 1911, the Government of India set up the Indian Research Fund
Association (IRFA) with the specific objective of sponsoring and
coordinating medical research in the country.
After independence, several important changes were made in the
organization and the activities of the IRFA
It was redesignated the Indian Council of Medical Research
(ICMR) in 1949, with expanded scope of functions &
responsibility.
The ICMR is funded by the Government of India through the
Ministry of Health and Family Welfare.
Sagar Savale
4 7/9/2016
5. The council not only plans & promotes medical research & emerging
health problems of the country but also is expected to build strong
national group of professional persons in organization of skilled
biomedical scientists.
Rapid advances in science & technology have brought in new
technologies to understand the disease process & find strategies for
prevention & cure.
Sagar Savale
5 7/9/2016
6. The policies of ICMR coincide with national health policies such as
-control and management of communicable diseases,
-fertility control,
-maternal and child health,
-control of nutritional disorders,
-developing alternative strategies for health care delivery,
-safety limits of environmental and occupational health problems,
-Non-communicable diseases including cancer, cardiovascular,
neurological, ophthalmic and haematological disorders.
Sagar Savale
6 7/9/2016
7. ICMR, with its 30 state-of-the-art Institutes/Centers, is
amongst research organizations in the field of Bio Medical
Sciences.
1. The Indian Council of Medical Research provides
financial assistance to promote biomedical and health research.
2. Proposals in fundamental research; development and
evaluation of a tool, Clinical and operational research are
considered for ICMR support.
Objective
Sagar Savale
7 7/9/2016
8. Indian Council Of Medical Research
Abbreviation ICMR
Type Professional
Organization
Headquarters New Delhi
Region served India
Secretary & Director
General
Dr. V.M. Katoch
Website http://www.icmr.nic.i
n/
Sagar Savale
8 7/9/2016
9. Governing Bodies
The supreme authority of the ICMR, is headed by the Minister
of Health, Government of India.
The Governing Body which is the chief executive and decision
making authority of the ICMR. It is headed by the Director-
General.
1. Union Health Minister.
2. Scientific Advisory Board.
-Scientific Advisory Group
-Scientific Advisory Committees
-Expert Groups.
-Task Forces.
-Steering Committees etc. which evaluate and monitor
different research activities of the Council.
Sagar Savale
9 7/9/2016
11. Organization Structure
Union Minister of Health is the ex-officio President of the ICMR
Society.
Health Secretary, Department of Health Research & Education,
Ministry of Health, Govt. of India,
Director-General, ICMR - the Principal Executive Officer of the
Council
Health Scientists' Recruitment Board
Deputy Directors-General
Additional Secretary and Secretary (ICMR)
Additional Secretary and Financial Advisor
Assistant Directors-General,
National Director, National Health Innovation Project
Directorate of Information and Publications of Health.Sagar Savale11 7/9/2016
12. Activities
The ICMR was constituted as an autonomous organization, with
the Union Health Minister as President of its Governing Body.
The Council promotes biomedical research in the country
through intramural research (through institutes totally funded by
ICMR) and extramural research (at college or university).
Sagar Savale
12 7/9/2016
13. Intramural Research
Intramural research is carried out currently through the
Council's 30 Research Institutes/Centres.
These include
19 mission-oriented national institutes :
National Jalma institute for Leprosy & Other Mycobacterial
Diseases (NCJILOMD), Agra.
National Institute of Occupational Health (NIOH), Ahmadabad.
Tuberculosis Research Centre (TRC), Chennai
National Institute of Malaria Research (NIMR), Delhi
National Institute for Research in Tuberculosis (NIRT),Chennai
National Institute of Pathology (NIP) ,Delhi
National Institute of Medical Statistics (NIMS),Delhi.
Sagar Savale
13 7/9/2016
14. National Institute for Research in Environmental Health
(NIREH),Bhopal
National Centre for Disease Informatics and Research, Bangalore
National Institute for Research in Reproductive Health
(NIRRH),Mumbai
National Institute of Immunohaemotology (NIIH),Mumbai
Enterovirus Research Centre (ERC),Mumbai
Institute of Cytology and Preventive Oncology (ICPO), Noida
Rajendra Memorial Research Institute of Medical Sciences
(RMRIMS), Patna
Vector Control Research Centre (VCRC), Pondicherry
National Institute of Virology (NIV),Pune
National AIDS Research Institute (NARI),Pune.
Sagar Savale
14 7/9/2016
15. 6 Regional Medical Research Centres :
Regional Medical Research Centre, Bhubaneswar
Regional Medical Research Centre, Port Blair
Regional Medical Research Centre, Jabalpur
Desert Medicine Research Centre, Jodhpur
Regional Medical Research Centre, Belgaum.
Sagar Savale
15 7/9/2016
16. 5 Unit/Centres :
Food & Drug Toxicology Research Centre, Hyderabad
National Centre of Laboratory Sciences, Hyderabad
ICMR Virus Unit, Kolkata
Genetic Research Centre, Mumbai
Microbial Containment Complex, Pune.
Sagar Savale
16 7/9/2016
17. Extramural Research
Extramural research is promoted by ICMR through Setting up
Centres for Advanced Research in selected departments of Medical
Colleges, Universities and other non-ICMR Research Institutes.
Task force studies with goal-oriented approach with clearly defined
targets.
Open-ended research in non-ICMR Research Institutes, Medical
colleges, Universities etc. located in different parts of the country.
Sagar Savale
17 7/9/2016
18. Fellowship & Schemes
The ICMR encourage human resources development in
biomedical research through various schemes such as
(1) Research Fellowships i.e. Junior and Senior Fellowships and
Research Associateships.
(2) Short-term Visiting Fellowships which allow scientists to learn
advanced research techniques from other well-established research
institutes in India.
(3) Short-term Research Studentships for undergraduate medical
students to encourage them to familiar themselves with research
methodologies and Techniques.
(4) Various Training Programme and Workshops conducted by ICMR
Institutes and Headquarters.
Sagar Savale
18 7/9/2016
19. National Health Programmes :
-National Malaria Eradication Programme
-National Filaria Control Programme
-National Leprosy Control Programme
-Diarrhoeal Diseases Control Programme
-National AIDS Control Programme
-National Cancer Control Programme
-Universal Immunization Programme
-National Tuberculosis Programme.
Sagar Savale
19 7/9/2016
20. Grant Schemes
Studentships
Short Term Research Studentship
Fellowships/ Associateships
Research Fellowships/ Associateships
Junior Research Fellowships
The schemes is aim at promoting good quality research in
medical colleges throught students persing post graduation
courses as well as improve visibility & accesslibility of their
research work.
Sagar Savale20 7/9/2016
21. Ethical Guidelines of ICMR
Ethical Guidelines for Biomedical Research on Human
Participants.
Executing research Policy.
Guidelines for Good Clinical Laboratory Practices.
National Guidelines for Accreditation, Supervision & Regulation
of ART Clinics in India.
Cancer Management Guidelines.
Guidelines for Stem Cell Research and Therapy .
Sagar Savale21 7/9/2016
22. Guidelines for Management of Type 2 Diabetes.
National Guidelines in the Management of Retinoblastoma.
'ICMR-DBT' Guidelines for evaluation of probiotics in food.
Dietary Guidelines.
ICMR should steer international collaborative health
research to ensure that the country derives maximum
Benefit and global goals are attained.
Sagar Savale22 7/9/2016
23. Periodical Publication
Indian Journal of Medical Research
ICMR Bulletins
Annual Reports of ICMR Headquarters & Other ICMR
Institutes & Other Institutes.
Health Research Policies
Guidelines.
Sagar Savale23 7/9/2016